NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib
- PMID: 22403810
- DOI: 10.1016/s1470-2045(12)70008-6
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical